• Standard BioTools Inc. in its strategic sale of SomaLogic to Illumina, Inc. for an upfront payment of $350mn in cash at closing and up to $75mn in cash in near-term milestone payments.
• Capella Space Corp., an aerospace company with data and satellite solutions for government and commercial applications, on its sale to IonQ, Inc., a quantum computing and networking company.
• Sonoco on its $3.9bn acquisition of Eviosys.
• AstraZeneca on its $1.05bn acquisition of Amolyt Pharma.
• AstraZeneca on its $2bn acquisition of Fusion Pharmaceuticals Inc.
• Global organizations and corporate clients on the antitrust and competition law aspects of individual ESG initiatives and sector/industry collaborations.
• Bucherer AG in its sale to a manufactoring company.  
• Sonoco Products Company on its $330 million in cash acquisition of the remaining equity interest in its joint venture with the WestRock Company, RTS Packaging, and one paper mill in Chattanooga, Tennessee.
• Zymergen on its $300 million sale to Ginkgo Bioworks—the first-ever sale of a publicly-listed public benefit corporation.
• Cargill, one of the largest private companies in the US, in the $4.53bn take-private of Nasdaq-listed Sanderson Farms and the concurrent combination of Sanderson Farms with privately-held Wayne Farms. 
• Stanley Black & Decker on the $3.2bn sale of its global electronic security solutions healthcare solutions businesses to Securitas AB.
• Sonoco on its $1.35bn acquisition of Ball Metalpack.
• AstraZeneca on its successful $39bn acquisition of Alexion including securing unconditional clearance in more than 20 antitrust and foreign direct investment jurisdictions. 
• ProAssurance on the antitrust considerations of its $441 million dollar acquisition of NORCAL.
• The London Stock Exchange Group on the US and global merger control aspects of its $27bn deal to acquire Refinitiv.
• Evonik during trial where we successfully defended the company against the FTC’s attempt to block its proposed acquisition of PeroxyChem, a competing hydrogen peroxide producer.
• Smiths Group, a London-listed global technology company, on the international competition and regulatory aspects of its acquisition of Morpho Detection, a California-based detection and security solutions company. Read more about the deal in our case study.
• Intel, a global manufacturer of computer microprocessors and computing devices and leader in the server and semiconductor processing chips industry, on its $16.7bn acquisition of Altera.
• Novartis on two multibillion-dollar transactions: its joint venture with GlaxoSmithKline to form a world-leading consumer healthcare business; and the $5.4bn sale of its animal health business to Eli Lilly.
• Hapag-Lloyd, one of the largest container shipping lines in the world, on its merger with the container shipping activities of Chile’s Compania Sud Americana de Vapores (CSAV).
• In the defense of a US industrial manufacturer in an FTC Section 5 investigation of alleged anticompetitive co-ordination among US suppliers, resulting in closing of the investigation with no enforcement action.

Justin’s experience at the U.S. Federal Trade Commission includes:

• In the Matter of Fidelity National Financial, Inc. and Lender Processing Services (2014);
• In the Matter of Bosley, Inc., a corporation, and Aderans America Holdings, Inc., a corporation, and Aderans Co., Ltd., a corporation (2013);
• In the Matter of CoStar Group, Inc., Lonestar Acquisition Sub, Inc., and LoopNet, Inc (2012); and
• In the Matter of Pilot Corporation, et al. (2010).